{"organizations": [], "uuid": "aa11a731bdadd8cc4b8bae2d95dfb50c29095c6b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-alliqua-biomedical-says-has-right/brief-alliqua-biomedical-says-has-right-to-terminate-agreement-with-celularity-provided-co-pays-1-45-mln-fee-idUSFWN1P011E", "country": "US", "domain_rank": 408, "title": "BRIEF-Alliqua Biomedical Says Has Right To Terminate Agreement With Celularity, Provided Co Pays $1.45 Mln Fee", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-06T00:22:00.000+02:00", "replies_count": 0, "uuid": "aa11a731bdadd8cc4b8bae2d95dfb50c29095c6b"}, "author": "", "url": "https://www.reuters.com/article/brief-alliqua-biomedical-says-has-right/brief-alliqua-biomedical-says-has-right-to-terminate-agreement-with-celularity-provided-co-pays-1-45-mln-fee-idUSFWN1P011E", "ord_in_thread": 0, "title": "BRIEF-Alliqua Biomedical Says Has Right To Terminate Agreement With Celularity, Provided Co Pays $1.45 Mln Fee", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-alliqua biomedical says has right to terminate agreement with celularity", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "alliqua biomedical inc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 5, 2018 / 10:23 PM / Updated 6 minutes ago BRIEF-Alliqua Biomedical Says Has Right To Terminate Agreement With Celularity, Provided Co Pays $1.45 Mln Fee Reuters Staff 1 Min Read \nJan 5 (Reuters) - Alliqua Biomedical Inc: \n* ALLIQUA BIOMEDICAL SAYS HAS RIGHT TO TERMINATE ASSET PURCHASE AGREEMENT WITH CELULARITY, PROVIDED CO PAYS TERMINATION FEE OF $1.45 MILLION - SEC FILING \n* ALLIQUA BIOMEDICAL INC - CELULARITY MAY BE OBLIGATED TO PAY A $3 MILLION REVERSE TERMINATION FEE IF ASSET PURCHASE AGREEMENT IS TERMINATED BY CO Source text for Eikon: ( bit.ly/2CMZUYM ) Further company coverage:", "external_links": [], "published": "2018-01-06T00:22:00.000+02:00", "crawled": "2018-01-06T00:39:28.003+02:00", "highlightTitle": ""}